Please login to the form below

Not currently logged in

Y-mAbs Therapeutics

This page shows the latest Y-mAbs Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Y-mAbs files breakthrough neuroblastoma drug in US

Y-mAbs files breakthrough neuroblastoma drug in US

Rare cancer type mostly affects babies and young children. Y-mAbs Therapeutics has filed the first of the two antibody drugs it intends to submit to the FDA, starting with naxitamab ... Y-mAbs reported new results from its main phase 3 naxitamab study at

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...

Latest intelligence

Box 1
Strategic commitment
KOL Ambassador Program & Podcast Creation: A Customer Story
Animation: Living With
The journey from the patient's perspective...